ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-19 Cr | ₹17 Cr | ₹-184 Cr | ₹70 Cr | ₹111 Cr |
What is the latest Net Cash Inflow / Outflow ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹-19 Cr |
Mar2024 | ₹17 Cr |
Mar2023 | ₹-184 Cr |
Mar2022 | ₹70 Cr |
Mar2021 | ₹111 Cr |
How is Net Cash Inflow / Outflow of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹-19 Cr | Negative | |
Mar2024 | ₹17 Cr | Positive | |
Mar2023 | ₹-184 Cr | Negative | |
Mar2022 | ₹70 Cr | -36.68 | |
Mar2021 | ₹111 Cr | - |
Compare Net Cash Inflow / Outflow of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,434.8 Cr | 0.8% | -6.4% | -26.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | 0.8% |
-6.4% |
-26.5% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses